Form 13-F position report

ARK GENOMIC REVOLUTION ETF (DE

Reported by Florin Court Capital LLP

ARKG CUSIP 00214Q302 Manager CIK 0001696263

Reported 266,700 shares, up 239,000 (862.8%) from the prior quarter.

Reported value 1141.2%; share count 862.8% vs. the prior quarter.

Added
% of reported 13F value 14.92% This manager · Q3 2026
Shares 266,700 Quarter-end amount reported
Reported value $14,460,474 Fair value at quarter end
Consecutive quarters held 5 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-09-30 880309
2025-12-31 854615
2026-03-31 0
2026-06-30 1165062
2026-09-30 14460474

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for ARK GENOMIC REVOLUTION ETF (DE held by Florin Court Capital LLP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 266,700 +239,000 (862.8%) 14.92% $14,460,474 2026-11-02
Q2 2026 New 27,700 +27,700 (0.0%) 1.9% $1,165,062 2026-08-04
Q1 2026 Reduced 0 -29,500 (-100.0%) 0 $0 2026-05-06
Q4 2025 Reduced 29,500 -2,200 (-6.9%) 1.19% $854,615 2026-02-05
Q3 2025 New 31,700 +31,700 (0.0%) 0.69% $880,309 2025-11-03

Who else reported the position

349 managers reported ARK GENOMIC REVOLUTION ETF (DE for Q3 2026.

Managers reporting ARK GENOMIC REVOLUTION ETF (DE in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
JPMorgan Chase & Co Reduced 6,972,027 -471,269 0.02% $376,140,889 28 qtrs
MORGAN STANLEY Added 6,927,982 +204,771 0.02% $375,635,261 37 qtrs
Bank of America Corporation Added 2,521,149 +1,606,472 < 0.01% $136,696,680 35 qtrs
The Goldman Sachs Group Inc Reduced 2,206,762 -810,201 0.01% $119,650,636 24 qtrs
JEFFERIES FINANCIAL GROUP INC Reduced 1,500,000 -300,113 0.6% $81,330,000 3 qtrs
UBS Group AG Reduced 1,266,746 -319,099 < 0.01% $68,682,968 35 qtrs
STATE OF WISCONSIN INVESTMENT BOARD Added 1,109,799 +75,423 0.12% $60,173,302 20 qtrs
LPL Financial LLC Added 1,028,563 +110,931 0.01% $55,768,667 39 qtrs
CITADEL ADVISORS LLC New 779,104 +779,104 < 0.01% $42,243,019 34 qtrs
Citigroup Inc Reduced 689,700 -1,482,615 0.01% $37,395,534 35 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 02, 2026
Filing type
13F-HR
Position type
GENOMIC REV ETF

Voting authority reported

Sole
266,700
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.